FDA Approves Vyxeos
FDA Approves Vyxeos (daunorubicin and cytarabine) Liposome for Injection for Certain Types of Poor-Prognosis Acute Myeloid Leukemia
FDA Approves Vyxeos (daunorubicin and cytarabine) Liposome for Injection for Certain Types of Poor-Prognosis Acute Myeloid Leukemia
FRIDAY, July 28, 2017 -- The U.S. Food and Drug Administration will focus on reducing nicotine levels in cigarettes to make them less addictive, while also making other nicotine products -- including patches and gum -- safer, agency officials said Friday.
FRIDAY, July 28, 2017 -- The drug ketamine -- known as Special K on the party scene -- shows promise as a depression treatment. But researchers arent ready to recommend it because its long-term effects remain unknown. That gap in knowledge must be fill
FOSTER CITY, Calif.--(BUSINESS WIRE)--Jul. 18, 2017-- Gilead Sciences, Inc. (NASDAQ: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved Vosevi (sofosbuvir 400 mg/velpatasvir 100 mg/voxilaprevir 100 mg) tablets, a single-ta
FDA Approves Nerlynx (neratinib) for Extended Adjuvant Treatment of Early Stage HER2-Positive Breast Cancer
SATURDAY, July 15, 2017 -- Americans love flip-flops -- just slip them on, and youre out the door. But, the unstructured footwear can cause problems, one expert says. "This time of year I frequently see patients with foot conditions related to weari